Aims-The purpose of this study was to examine whether preoperative activity of rheumatoid arthritis influences the extent of anterior chamber inflammation after cataract extraction and intraocular lens implantation. Methods-The medical records of 23 consecutive patients (33 eyes) with rheumatoid arthritis, who underwent cataract extraction with intraocular lens implantation, were reviewed during a 4 year period from
extraction with intraocular lens implantation, were reviewed during a 4 year period from April 1990 to March 1994. Results-Eleven patients who still showed a 1+ level of aqueous cells 1 month after the surgery had significantly higher titres of rheumatoid factor preoperatively, compared with the other 12 patients who showed no aqueous cells (p=0.0019, Mann-Whitney U test). The persistence of aqueous cells also had a significant correlation with extracapsular cataract extraction compared with phacoemulsification (p=0.0391, x2 test). Multivariate analysis showed that the titre of rheumatoid factor was the more significant element to determine the persistent aqueous inflammation. All Each patient was given postoperatively a combination of 01% betamethasone sodium phosphate, 0 1 % diclofenac sodium, and 0 3% ofloxacin eye drops four times a day for 4 weeks after the surgery.
For statistical analyses, the eye that underwent cataract surgery earlier was chosen in each patient when both eyes had been operated on.17 18 Statistical analyses were done with a software STATVIEW (Macintosh) package.
Results
Thirty three eyes of 23 consecutive patients with rheumatoid arthritis underwent cataract surgery during the period. Planned extracapsular cataract extraction was performed in 16 eyes and phacoemulsification was done in the other 17 eyes. Extracapsular cataract extraction was concentrated in the initial phase because patients with maturer cataract underwent the surgery earlier. The cataract surgery was free of intraoperative complications, including capsular rupture, and intraocular lenses were implanted in the capsular bag of all the eyes. The age of the patients at surgery varied from 59 to 81 years and all the patients except for one (case 19) were female ( Table 1) . The follow up periods were from 3 months to 4 years.
Patients had the history of rheumatoid arthritis ranging from 5 to 33 years. Most of the patients received a low dose of prednisolone (2-5-7 5 mg) every day combined with other medications such as gold (auranofin), methotrexate, lobenzarit, bucillamine, or D-penicillamine for rheumatoid arthritis before the surgery (Table 1) . Doses of the medication, including prednisolone for rheumatoid arthritis, were not changed during a 3 month period after cataract surgery in all patients. Three patients had diabetes mellitus and seven patients had essential hypertension. Prednisolone was not given to these three diabetic patients. No patient showed exfoliation syndrome, or the previous history of uveitis, episcleritis, scleritis, or keratoconjunctivitis sicca.
All the eyes except four eyes gained best corrected visual acuity of 20/30 or better after cataract surgery. A macular hole, optic disc atrophy, or retinitis pigmentosa was found in these four eyes with poor visual outcome (Fig  1) . One eye (case 6) developed transient elevation of intraocular pressure up to 33 mm Hg 3 days after surgery, which returned to normal within 4 days without any medication. Other complications directly linked to the surgery, including cystoid macular oedema, were absent. One patient (case 12) died of lung cancer 6 months after surgery, and another patient (case 19) developed endogenous fungal endophthalmitis in both eyes and died in the course of intravenous hyperalimentation for general debilitation 5 months after surgery.
No eye had preoperative inflammation in the anterior chamber. All the eyes had some degree of aqueous inflammation 3 days and 1 week after the cataract surgery (Table 2) . Sixteen eyes still had a 1+ level of aqueous cells 1 month after surgery, while the other 17 eyes had no inflammation. Aqueous inflammation completely cleared in all eyes 3 months after surgery.
The extent of aqueous inflammation both 3 days and 1 week after the surgery did not have any correlation with preoperative activity of rheumatoid arthritis shown by white blood cell counts, erythrocyte sedimentation rates, serum levels of C-reactive proteins, or serum titres of rheumatoid factor. In other words, higher activity of rheumatoid arthritis did not necessarily lead to more marked aqueous inflammation immediately after intraocular lens implantation.
The presence or absence of aqueous cells 1 month after surgery is plotted against preoperative serum titres of rheumatoid factor, erythrocyte sedimentation rates, serum levels of C-reactive protein, and white blood cell counts (Fig 2) . Patients with no aqueous cells had lower titres of rheumatoid factors (median 17 IU/ml), while those with aqueous cells had the higher titres (median 231 IU/ml). The difference between the titres in the two groups was statistically significant (p=0 0019, MannWhitney U test). When the patients with aqueous cells were divided further arbitrarily into two groups: one group (seven patients) with titres of rheumatoid factors of 200 IU/ml or higher and the other group (four patients) with the titres of 100 IU/ml or lower, three patients out offour with the lower titres had diabetes mellitus (Fig 2) . This indicates that persistent aqueous inflammation in these patients with the low titres of rheumatoid factors could be attributed to diabetes mellitus. Erythrocyte sedimentation rates, serum levels of C-reactive protein, or white blood cell counts did not correlate with the presence or absence of aqueous cells 1 month after the surgery. Ten patients underwent cataract surgery in both eyes separately. The presence or absence of aqueous inflammation 1 month after surgery was consistent between both eyes in all 10 patients. Extracapsular cataract extraction was performed in 12 out of 16 eyes which showed persistent aqueous inflammation 1 month after surgery, while phacoemulsification was performed in 13 out of 17 eyes which showed no aqueous cells at the same time. When one eye operated on earlier was chosen for statistical analysis in patients who underwent surgery in both eyes, the persistence of aqueous cells 1 month after surgery had a significant correlation with extracapsular cataract extraction compared with phacoemulsification (Fisher's exact, p=0-0391, x2 test).
Multivariate analysis of the data showed that the titre of rheumatoid factor was the more significant element to determine the persistent aqueous inflammation than was the difference in the surgical procedure (p=00008 versus p=0-0046, multiple regression analysis). The present study demonstrated that the presence or absence of aqueous inflammation 1 month after cataract extraction and intraocular lens implantation had a positive correlation with preoperative serum titres of rheumatoid factors. The patients with higher titres of rheumatoid factor developed persistent aqueous inflammation 1 month after surgery. However, no correlation was found between the presence or absence of aqueous cells and other factors including erythrocyte sedimentation rates, Creactive protein, and white blood cell counts. This discrepancy can be explained by the fact that erythrocyte sedimentation rates, C-reactive proteins, and white blood cell counts are influenced not only by activity of rheumatoid arthritis but also by inflammation of other origin. In the present study, patients with many variables were analysed retrospectively. For example, patients underwent either extracapsular cataract extraction or phacoemulsification. These different surgical methods naturally influenced the extent of postoperative aqueous inflammation. Extracapsular cataract extraction appears to have been performed more frequently on patients with higher titres of rheumatoid factor, possibly because these patients had more mature cataract and were operated on in the initial phase of the study.
Although the persistent aqueous inflammation in this series could be attributed in part to extracapsular cataract extraction, multivariate analysis clearly demonstrated that the titre of rheumatoid factor was the more significant element in determining the delayed aqueous inflammation.
Furthermore, the patients took different combinations of the medication for rheumatoid arthritis and had systemic diseases other than rheumatoid arthritis. Oral prednisolone can reduce postoperative inflammation, while patients with diabetes mellitus usually have persistent and severe inflammation after cataract surgery. Further study will be required to confirm the positive correlation between rheumatic activity and persistent aqueous inflammation after cataract surgery in patients with rheumatoid artiritis.
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